Literature DB >> 25308065

Targeted local therapy in oligometastatic prostate cancer: a promising potential opportunity after failed primary treatment.

Fairleigh Reeves1, Declan Murphy1,2,3, Christopher Evans4, Patrick Bowden3, Anthony Costello1,3.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25308065     DOI： 10.1111/bju.12957

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  2 in total

Review 1.  The biology and treatment of oligometastatic cancer.

Authors:  Diane K Reyes; Kenneth J Pienta
Journal:  Oncotarget       Date:  2015-04-20

2.  [18F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trial.

Authors:  Rachel M Glicksman; Ur Metser; John Valliant; Peter W Chung; Neil E Fleshner; Robert G Bristow; David Green; Antonio Finelli; Robert Hamilton; Teodor Stanescu; Douglas Hussey; Charles Catton; Mary Gospodarowicz; Padraig Warde; Andrew Bayley; Stephen Breen; Doug Vines; David A Jaffray; Alejando Berlin
Journal:  BMJ Open       Date:  2020-04-22       Impact factor: 2.692
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.